Evaluating the Impact of COVID-19 on the Adoption of Virtual Care in General Practice in 20 Countries (inSIGHT): Protocol and Rationale Study

Carregando...
Imagem de Miniatura
Citações na Scopus
6
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
JMIR PUBLICATIONS, INC
Autores
NEVES, Ana Luisa
LI, Edmond
SERAFINI, Alice
JIMENEZ, Geronimo
LINGNER, Heidrun
KOSKELA, Tuomas H.
HOFFMAN, Robert D.
COLLINS, Claire
PETEK, Davorina
CLAVERIA, Ana
Citação
JMIR RESEARCH PROTOCOLS, v.10, n.8, article ID e30099, 9p, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Background: In recent decades, virtual care has emerged as a promising option to support primary care delivery. However, despite the potential, adoption rates remained low. With the outbreak of COVID-19, it has suddenly been pushed to the forefront of care delivery. As we progress into the second year of the COVID-19 pandemic, there is a need and opportunity to review the impact remote care had in primary care settings and reassess its potential future role. Objective: This study aims to explore the perspectives of general practitioners (GPs) and family doctors on the (1) use of virtual care during the COVID-19 pandemic, (2) perceived impact on quality and safety of care, and (3) essential factors for high-quality and sustainable use of virtual care in the future. Methods: This study used an online cross-sectional questionnaire completed by GPs distributed across 20 countries. The survey was hosted in Qualtrics and distributed using email, social media, and the researchers' personal contact networks. GPs were eligible for the survey if they were working mainly in primary care during the period of the COVID-19 pandemic. Descriptive statistical analysis will be performed for quantitative variables, and relationships between the use of virtual care and perceptions on impact on quality and safety of care and participants' characteristics may be explored. Qualitative data (free-text responses) will be analyzed using framework analysis. Results: Data collection took place from June 2020 to September 2020. As of this manuscript's submission, a total of 1605 GP respondents participated in the questionnaire. Further data analysis is currently ongoing. Conclusions: The study will provide a comprehensive overview of the availability of virtual care technologies, perceived impact on quality and safety of care, and essential factors for high-quality future use. In addition, a description of the underlying factors that influence this adoption and perceptions, in both individual GP and family doctor characteristics and the context in which they work, will be provided. While the COVID-19 pandemic may prove the first great stress test of the capabilities, capacity, and robustness of digital systems currently in use, remote care will likely remain an increasingly common approach in the future. There is an imperative to identify the main lessons from this unexpected transformation and use them to inform policy decisions and health service design. International Registered Report Identifier (IRRID): DERR1-10.2196/30099
Palavras-chave
primary care, telemedicine, virtual care, digital-first models, quality of care, patient safety
Referências
  1. Alexander GC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21476
  2. [Anonymous], 2017, VIR ZDRAVSTV
  3. [Anonymous], 2014, GEN PRACT TOT
  4. [Anonymous], Sistema de Informacion Sanitaria
  5. [Anonymous], 2021, GEN PRACT WORKF 31 D
  6. [Anonymous], 2003, NEW HLTH SYST 21 CEN
  7. [Anonymous], 2018, HLTH GLANC EUR, DOI [10.1787/health_glance_eur-2018-en, DOI 10.1787/HEALTH_GLANCE_EUR-2018-EN]
  8. [Anonymous], 2017, INF BRECH PERS SAL S
  9. [Anonymous], 2019, HLTH WORKF DAT
  10. [Anonymous], 2018, HLTH STAT YB 2018
  11. [Anonymous], 2020, DISTR ESP ID SEX
  12. [Anonymous], 2018, MARK STUD TEL
  13. [Anonymous], 2018, FAM MED PROF
  14. [Anonymous], 2019, CROAT HLTH STAT YB 2
  15. [Anonymous], 2018, EHEALTH AD PRIM HEAL
  16. Bashshur R, 2020, TELEMED E-HEALTH, V26, P571, DOI 10.1089/tmj.2020.29040.rb
  17. Basu S, 2019, JAMA INTERN MED, V179, P506, DOI 10.1001/jamainternmed.2018.7624
  18. Bonevski B, 2011, AUST FAM PHYSICIAN, V40, P427
  19. Braun V, 2020, INT J SOC RES METHOD, DOI 10.1080/13645579.2020.1805550
  20. Car J, 2020, BMJ-BRIT MED J, V371, pM3945, DOI [DOI 10.1136/bmj.m3945, 10.1136/bmj.m3945]
  21. Collins C, 2021, BMC FAM PRACT, V22, DOI 10.1186/s12875-021-01377-0
  22. Daniel WW, 1995, BIOMETRICS, V51, P386, DOI [10.2307/2533362, DOI 10.2307/2533362]
  23. Davis Fred D., 1985, TECHNOLOGY ACCEPTANC
  24. Dobrow MJ, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1090
  25. Flint J., 2001, SOC RES UPDATE, V33, P1, DOI 10.1017/CBO9781107415324.004
  26. Flott K, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5047
  27. Grossman Z, 2020, ISR J HEALTH POLICY, V9, DOI 10.1186/s13584-020-00414-0
  28. Hair J.F.., 2009, MULTIVARIATE DATA AN, V7th
  29. Harvey JB, 2019, TELEMED E-HEALTH, V25, P132, DOI 10.1089/tmj.2017.0265
  30. Irving G, 2021, BMJ OPEN QUAL, V10, DOI 10.1136/bmjoq-2020-001081
  31. Klein RB., 2015, PRINCIPLES PRACTICE, VFourth
  32. Krelle H, 2020, JAMA HLTH FORUM, V7, DOI [https://doi.org/10.1001/jamahealthforum.2020.0900, DOI 10.1001/JAMAHEALTHFORUM.2020.0900, 10.1001/jamahealthforum.2020.0900]
  33. Kurotschka PK, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.623904
  34. Liao CC, 2009, INT J INFORM MANAGE, V29, P309, DOI 10.1016/j.ijinfomgt.2009.03.004
  35. McNeish DM, 2016, EDUC PSYCHOL REV, V28, P295, DOI 10.1007/s10648-014-9287-x
  36. Murphy M, 2021, BRIT J GEN PRACT, V71, pE166, DOI 10.3399/BJGP.2020.0948
  37. Paul Rene Ocampo T, 2018, ESTIMACION OFERTA ME
  38. Pearl R, 2014, HEALTH AFFAIR, V33, P251, DOI 10.1377/hlthaff.2013.1005
  39. Pit SW, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-76
  40. Portz JD, 2019, J MED INTERNET RES, V21, DOI 10.2196/11604
  41. Ritchie J., 1994, ANAL QUALITATIVE DAT, P173, DOI 10.4324/9780203413081_CHAPTER_9
  42. Scheffer M, 2020, DEMOGRAFIA MED BRASI
  43. Shaghaghi A, 2011, HEALTH PROMOT PERSPE, V1, P86, DOI 10.5681/hpp.2011.009
  44. Ting DSW, 2020, NAT MED, V26, P459, DOI 10.1038/s41591-020-0824-5
  45. Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042
  46. van Galen LS, 2018, BMJ-BRIT MED J, V360, pK1047, DOI [10.1136/bmj.k1047, DOI 10.1136/bmj.k1047]
  47. von Elm E, 2007, LANCET, V370, P1453, DOI [10.1371/journal.pmed.0040296, 10.1157/13119325, 10.1016/S0140-6736(07)61602-X]